Back to Search
Start Over
Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis.
- Source :
-
Journal of neuroimmunology [J Neuroimmunol] 1999 May 03; Vol. 96 (2), pp. 158-66. - Publication Year :
- 1999
-
Abstract
- Blockade of the CD28-B7 or CD40L-CD40 T cell costimulatory signals prevents induction of experimental autoimmune encephalomyelitis (EAE). However, the effect of simultaneous blockade of these signals in EAE is unknown. We show that administration of either MR1 (to block CD40L) or CTLA4Ig (to block B7) after immunization or after the first attack protects from EAE. Treatment with a combination of CTLA4Ig and MR1 provides additive protection, and is associated with complete absence of mononuclear cell infiltrates in the central nervous system, and marked suppression of proliferation of primed T cells in the periphery. Selective B7-1 blockade did not protect from EAE. These observations have implications for therapy of autoimmune diseases.
- Subjects :
- Abatacept
Animals
Antigens, CD
Antigens, Differentiation pharmacology
CD40 Ligand
CTLA-4 Antigen
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Synergism
Encephalomyelitis, Autoimmune, Experimental pathology
Female
Immunosuppressive Agents pharmacology
Membrane Glycoproteins administration & dosage
Mice
Myelin Basic Protein pharmacology
Recurrence
T-Lymphocytes drug effects
Time Factors
B7-1 Antigen pharmacology
CD28 Antigens pharmacology
Encephalomyelitis, Autoimmune, Experimental prevention & control
Immunoconjugates
Membrane Glycoproteins pharmacology
Signal Transduction drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0165-5728
- Volume :
- 96
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of neuroimmunology
- Publication Type :
- Academic Journal
- Accession number :
- 10337914
- Full Text :
- https://doi.org/10.1016/s0165-5728(99)00022-3